Skyscape Inc.

03/12/2026

A large clinical trial is performed to evaluate the treatment response to statins in statin-naive patients admitted for angina chest pain. Patients are randomly assigned to moderate- or high-dose statin therapy upon discharge. At 3 months, the adverse cardiovascular event rate in the high-dose group compared to the moderate-dose group was 0.98 with a p value of 0.80. At 1 year, the relative risk ratio was 0.67 with a p value of 0.01. Treatment and follow-up compliance was high in both groups throughout the study interval. The difference between the 2 risk estimates is best explained by which of the following?

A. Confounding bias
B. Latency period
C. Observer bias
D. Selection bias
E. Selective survival bias

For the correct answer please visit link in bio or https://hubs.la/Q046C-kK0
,

A large clinical trial is performed to evaluate the treatment response to statins in statin-naive patients admitted for angina chest pain. Patients are randomly assigned to moderate- or high-dose statin therapy upon discharge. At 3 months, the adverse cardiovascular event rate in the high-dose group...

03/11/2026

Test your knowledge, answer this week’s
The nurse is caring for a client returning to the medical-surgical unit after a total thyroidectomy. Which assessment finding indicates a related electrolyte deficiency?

1. Nuchal rigidity
2. Difficulty breathing
3. Facial nerve irritability
4. Development of premature ventricular contractions

For the correct answer, please visit: https://hubs.la/Q046rr0y0

#‎nclex ‪ #‎nursing ‪ #‎nclexqowskyscape

The nurse is caring for a client returning to the medical surgical unit after a total thyroidectomy. Which assessment finding indicates a related electrolyte deficiency?

03/07/2026

Today’s MedBeats: The safety profile and initial clinical improvement support the continued development of zorevunersen as a potential disease-modifying treatment for Dravet syndrome.

The safety profile and initial clinical improvement support the continued development of zorevunersen as a potential disease-modifying treatment for Dravet syndrome.

03/05/2026

Test your knowledge, answer this
A 12-year-old girl is brought to the clinic by her parents for evaluation of decreased exercise tolerance and increased lethargy. Her parents say she becomes short of breath with minimal exertion, and for the past 2 weeks her gums have bled when she brushes her teeth. Temperature is 36. 7 C (98 F); blood pressure and pulse are normal. Physical examination demonstrates pallor and hepatosplenomegaly. An extensive workup indicates that the patient has acute lymphoblastic leukemia, and the parents are informed that she will need chemotherapy. The parents do not consent to the treatment plan because they believe that the side effects will be too severe and that their child's quality of life will be poor. Despite an ethics consultation and a lengthy discussion about the benefits of treatment and likely consequences if therapy is withheld, the parents insist on taking her home without scheduling follow-up treatment. Which of the following is the most appropriate next step in the management of this patient?
A. Comply with the parents' wishes
B. Obtain a court order for chemotherapy
C. Proceed with chemotherapy immediately
D. Provide supportive treatment only
E. Recommend transfer of care to another provider

For the correct answer please visit: https://bit.ly/4sqNQku
,

A 12-year-old girl is brought to the clinic by her parents for evaluation of decreased exercise tolerance and increased lethargy. Her parents say she becomes short of breath with minimal exertion, and for the past 2 weeks her gums have bled when she brushes her teeth. Temperature is 36. 7 C (98 F);....

03/05/2026

Today’s MedBeats: Hospice-eligible patients frequently have renally cleared medications prescribed and at doses too high for their renal function. Analgesics, over-the-counter antihistamines, anticoagulants, anticholinergics have potential for significant adverse effects and higher vigilance is needed.

Hospice-eligible patients frequently have renally cleared medications prescribed and at doses too high for their renal function. Analgesics, over-the-counter antihistamines, anticoagulants, anticholinergics have potential for significant adverse effects and higher vigilance is needed.

03/05/2026

Today’s MedBeats: In the IMPACT-1 randomized clinical trial including adults with severe PTSD, intermittent treatment with TSND-201 (4 doses, 1 week apart) was generally well tolerated, safe, and associated with statistically significant and clinically meaningful improvements in PTSD symptoms that persisted well beyond the initial dosing period. Results support the further development of TSND-201 as a potential acute, intermittent treatment for PTSD. Together, these results demonstrate that TSND-201 has the potential to be a highly efficacious, rapid-acting and durable medication for PTSD. These promising results will require replication in larger upcoming studies.

In the IMPACT-1 randomized clinical trial including adults with severe PTSD, intermittent treatment with TSND-201 (4 doses, 1 week apart) was generally well tolerated, safe, and associated with statistically significant and clinically meaningful improvements in PTSD symptoms that persisted well beyo...

03/04/2026

Test your knowledge, answer this week’s
The nurse is planning care for a client with ineffective chronic pain management. Which goal is most appropriate?

1. Attend weekly pain management support group
2. State two activities to use as a diversion from pain
3. Keep a daily log of pain levels and intervention effectiveness
4. Demonstrate oral and topical pain medication administration

For the correct answer, please visit: https://bit.ly/4uaPYyc

#‎nclex ‪ #‎nursing ‪ #‎nclexqowskyscape

A client is recovering from an open cholecystectomy. Which finding indicates increased risk for a postoperative complication?

03/04/2026

💡 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐒𝐚𝐟𝐞𝐭𝐲 - 𝐀𝐯𝐨𝐢𝐝 𝐆𝐮𝐞𝐬𝐬𝐰𝐨𝐫𝐤, 𝐌𝐚𝐤𝐞 𝐞𝐯𝐞𝐫𝐲 𝐈𝐕 𝐜𝐨𝐦𝐩𝐚𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞.

When it comes to IV medications, compatibility and stability are critical ⚠️

𝐀𝐒𝐇𝐏 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐃𝐫𝐮𝐠 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐀𝐩𝐩 𝐞𝐧𝐚𝐛𝐥𝐞𝐬 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐫𝐮𝐬𝐭𝐞𝐝 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐭 𝐭𝐡𝐞 𝐏𝐨𝐢𝐧𝐭 𝐨𝐟 𝐂𝐚𝐫𝐞

𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬:
✅ 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲 𝐜𝐡𝐞𝐜𝐤 𝐈𝐕 𝐜𝐨𝐦𝐩𝐚𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 before co-administration
✅ 𝐕𝐞𝐫𝐢𝐟𝐲 𝐬𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐝𝐚𝐭𝐚 for safer preparation & storage
✅ 𝟒𝟎𝟎+ 𝐢𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐝𝐫𝐮𝐠 𝐦𝐨𝐧𝐨𝐠𝐫𝐚𝐩𝐡𝐬 at the point of care
✅ 𝐒𝐞𝐚𝐦𝐥𝐞𝐬𝐬 access on 𝐌𝐨𝐛𝐢𝐥𝐞 & 𝐖𝐞𝐛

Powered by the trusted expertise of the American Society of Health-System Pharmacists — built for hospital and clinical pharmacy professionals who can’t afford guesswork.

🎉 𝐒𝐚𝐯𝐞 𝟏𝟓% 𝐰𝐢𝐭𝐡 𝐜𝐨𝐝𝐞: 𝐒𝐎𝐂𝐈𝐀𝐋𝟏𝟓

👉 Tap to access now!

https://www.skyscape.com/product/ashp-injectable-drug-information

03/03/2026

- Our clients are raving about Buzz’s HIPAA-compliant messaging! Check out this glowing review from a happy customer. Visit https://bit.ly/4l1jHFG to learn more about Buzz or click the link in the bio.

03/03/2026

Today’s MedBeats: Complication rates were low after vaginal hysterectomy and laparoscopic hysterectomy. The study results suggest that vaginal hysterectomy is not clearly a preferred route for hysterectomy over laparoscopic hysterectomy. The data support further investigation of the optimal surgical approach for hysterectomy with large, prospective clinical studies.

Complication rates were low after vaginal hysterectomy and laparoscopic hysterectomy. The study results suggest that vaginal hysterectomy is not clearly a preferred route for hysterectomy over laparoscopic hysterectomy. The data support further investigation of the optimal surgical approach for hyst...

03/02/2026

🚀 Clear Drug Guidance. Better Patient Care. 💊

Busy Care Providers — stop struggling to explain complex medications.
AHFS Patient Drug Information | Mobile & Web gives you trusted, patient-friendly drug information anytime, anywhere.

Why It Matters:
➤ Easy-to-understand medication guidance
➤ Evidence-based content from American Society of Health-System Pharmacists
➤ Wide drug coverage
➤ Seamless access on the Skyscape app

🔥 𝗦𝗮𝘃𝗲 𝟭𝟱% – 𝗨𝘀𝗲 𝗖𝗼𝗱𝗲: 𝗦𝗢𝗖𝗜𝗔𝗟𝟭𝟱

Explain clearly. Educate confidently. Improve patient outcomes. 📲



https://www.skyscape.com/product/ahfs-patient-drug-information

03/01/2026

🩺 MedBeats: Voriconazole was not superior to itraconazole for treating chronic pulmonary aspergillosis and was associated with a significantly higher incidence of adverse events. Our findings support the continued use of itraconazole as the preferred therapy for chronic pulmonary aspergillosis, although voriconazole remains a reasonable alternative. The choice between the two agents should be guided by factors such as patient tolerance, drug availability, and cost considerations.

Voriconazole was not superior to itraconazole for treating chronic pulmonary aspergillosis and was associated with a significantly higher incidence of adverse events. Our findings support the continued use of itraconazole as the preferred therapy for chronic pulmonary aspergillosis, although voricon...